Detalles de la búsqueda
1.
Profile of patients with inflammatory bowel disease in conjunction with unmet needs and decision-making for choosing a new biologic therapy: a baseline analysis of the VEDOIBD-Study.
Int J Colorectal Dis
; 36(11): 2445-2453, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963913
2.
Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn's Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study.
Inflamm Bowel Dis
; 29(11): 1741-1750, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633301
3.
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study.
Inflamm Bowel Dis
; 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37523666
4.
Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naïve patients with ulcerative colitis: A two-year propensity-score-adjusted analysis from the prospective, observational VEDOIBD -study.
Aliment Pharmacol Ther
; 58(4): 429-442, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37322825
Resultados
1 -
4
de 4
1
Próxima >
>>